Up a level |
Ghaneh, Paula, Hanson, Robert, Titman, Andrew, Lancaster, Gill, Plumpton, Catrin, Lloyd-Williams, Huw, Yeo, Seow Tien, Edwards, Rhiannon Tudor, Johnson, Colin, Abu Hilal, Mohammed et al (show 30 more authors)
(2018)
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.
HEALTH TECHNOLOGY ASSESSMENT, 22 (7).
1-+.
Aughton, Karen ORCID: 0000-0002-5184-5789, Elander, Nils O, Evans, Anthony ORCID: 0000-0001-8547-1730, Jackson, Richard, Campbell, Fiona, Costello, Eithne, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Mackey, John R, Scarfe, Andrew G, Valle, Juan W et al (show 16 more authors)
(2021)
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
CANCERS, 13 (22).
5758-.